Advancements in Next-Generation Sequencing (NGS) and bioinformatics have given the microbiome field unprecedented insight into previously lesser understood microbial communities in and on the human body.
Through this insight, there has been a huge increase in R&D related to the skin microbiome and what impact this may have on skin health and disease. From pioneering academic research into various skin pathologies such as Psoriasis, Acne & Atopic Dermatitis to companies developing novel therapeutic and cosmetic products which seek to address patient and consumer needs.
CosmosID helps fuel this research through its CLIA/GLP facility, standardized workflows and industry-leading bioinformatics to generate unbiased sequencing data and strain-level resolution of bacteria, viruses, phages, fungi, protists, AMR & Virulence Factors.
Join CosmosID’s resident Molecular Biology expert, Dr Arne Materna, as he walks you through how to design and execute a skin microbiome study as well as showcase unseen strain-level insights into samples collected from Psoriasis patients.